The Chain: Protein Engineering Podcast

In this Science Commune segment, Dr. Daniel Chen and Dr. Pablo Umaña discuss what it means to be both a scientist and an engineer while utilizing principles from both disciplines to solve problems and advance innovation. 

Dr. David Wood is working on novel technology with self-cleaving tags, but he knows the importance of failure in the grand scheme of success, as well as mentorship, making your own way, and going your own speed.  

Sara Mangsbo is Entrepreneur of the Year, but her journey to success is much more than one title or one year. She shares the process and her biggest takeaways of building a company that is developing novel immunotherapies to fight cancer.  

In the fight against Coronavirus, there have been many calls for widespread testing. Dr. Nathan Ledeboer explains the power diagnostic testing has when combatting a pandemic, and the importance for collaboration in innovation during this time.  

The coronavirus has swept the globe, bringing governments, economies, and society to its knees. Infectious disease expert, Dr. Rita Rio discusses current suppression policies and long-term implications for the public, as well as healthcare systems and the scientific community. 

Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics.  In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.

Science Commune is a segment of The Chain that goes beyond the science and explores the people making discoveries. We discuss their career paths, passions, and the people who inspired them along the way. Join Dr. Daniel Chen as he speaks with Dr. Bruce Keyt, who is the Chief Scientific Officer at IGM Biosciences about connections between engineers, biologists, artists, and the inspiration that sparks innovation. 

Hank Greely, JD is a leading expert in law, and particularly its applications in scientific advancement, and the ethical concerns brought about by gene editing, specifically. Recent events, including the He Jiankui case, have captured international attention as the scientific community, national governments, and citizens of the world ask, “How far is too far?” when it comes to gene editing. Dr. Greely lends his insight into the case and shares the biggest lessons we can learn and apply to future advancements. 

Today’s episode continues the conversation with the 2019 and 2020 PEGS Young Scientist Keynote speakers, focusing on the challenges of their day to day work, the translation of major biotherapeutic and vaccine projects into the clinic and tips for young scientists considering careers in the field. 

Today’s episode features a conversation with the 2019 and 2020 PEGS Young Scientist Keynote presenters. We explore their work in protein science, its impact on global health and some exciting initiatives now underway in their labs.